Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers
Clinical trial NCT05730842 · COMPLETED
Trial details
- NCT number
- NCT05730842
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2023-04-06
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.